MAOB, monoamine oxidase B, 4129

N. diseases: 152; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.340 Biomarker disease BEFREE The second main outcome was to evaluate the association between MAO-B VT in the PFC and duration of major depressive disorder illness. 30840042 2019
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.340 Biomarker disease BEFREE Selegiline is an irreversible monoamine oxidase-B (MAO-B) inhibitor, and is widely used in the treatment of PD and major depression. 28515684 2017
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.340 Biomarker disease BEFREE Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect. 19657584 2009
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.340 Biomarker disease PSYGENET Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect. 19657584 2009
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.340 Biomarker disease PSYGENET Our data provide first suggestive evidence that the MAOB A644G SNP is involved in the outcome of treatment with mirtazapine or paroxetine in females with major depression. 17640790 2007
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.340 GeneticVariation disease BEFREE Our data provide first suggestive evidence that the MAOB A644G SNP is involved in the outcome of treatment with mirtazapine or paroxetine in females with major depression. 17640790 2007